Skip to main content
Earnings Labs
Replimune Group, Inc. logo

Replimune Group, Inc. (REPL) Earnings

NASDAQ·Healthcare·Biotechnology

$14.14

+8.85%

Mkt Cap $1.23B

EPS — Estimate vs Actual

Mkt Cap

$1.23B

P/E

—

Fwd P/E

—

P/S

—

Rev TTM

—

EPS TTM

-$3.58